资讯

A new HIV drug promises 99.9% protection. But it's making Indian health activists wary; Why?
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
Metro Weekly1 天
FDA Approves PrEP Drug Requiring Only Two Injections Per Year
Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...
Hoodline1 天
Multnomah County Health Officials Warn of Suspected Botulism Case Tied to Counterfeit Injection
Multnomah County reports a suspected botulism case after a resident received a botulinum toxin injection from an unlicensed ...
MPR2 天
Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
The FDA Just Approved a Long-Lasting Injection to Prevent HIV
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
ConsumerAffairs2 天
FDA approves twice-yearly injection for HIV prevention
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...
Queerty3 天
FDA approves world’s first twice-yearly PrEP injection
The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Rolling Out3 天
99.9% breakthrough transforms HIV prevention forever
FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...
News On 63 天
HIV prevention drug lenacapavir approved by FDA as twice-yearly injection
Newly FDA-approved HIV prevention drug, Yeztugo, offers protection for six months—yet the need for a vaccine remains, say ...
WGAU Radio3 天
FDA approves first twice-a-year HIV prevention shot with near-perfect protection
The U.S. Food and Drug Administration has approved a groundbreaking new HIV prevention drug that offers near-total protection ...
FDA approves first twice-yearly injection that prevents HIV infection
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.